Verastem (VSTM) Inventory Average (2018 - 2026)

Verastem (VSTM) recorded quarterly Inventory Average of $2.1 million in Q1 2026, up 13.59% quarter-over-quarter from $1.8 million in Q4 2025.

Verastem (VSTM) Inventory Average (2018 - 2026) Analysis & Trends

Verastem's Inventory Average history runs 5 years deep, the most recent figure standing at $2.1 million for Q1 2026.

In Q1 2026, Inventory Average changed N/A year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $2.1 million (changed N/A YoY), while the FY2019 annual figure was $1.7 million, changed N/A from the prior year.
Inventory Average was $2.1 million for Q1 2026 at Verastem, up from $1.8 million in the prior quarter.
In the past five years, Inventory Average ranged from a high of $2.1 million in Q1 2026 to a low of $1.5 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory Avg. (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	30.59 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	1.73 Bn
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Verastem	407.42 Mn	225.74 Mn	15.90 Mn	2.06 Mn

Download Data